Direct chemical synthesis has been adapted to make oligonucleotides of remarkable length, including an 800 nucleotide green ...
Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction ... and revenue surprises of 3.03% and 1.63%, respectively, for the quarter ...
Pfizer Inc. today announced positive results from the Phase 3 TALAPRO-2 study of TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI® (enzalutamide ...
STONY BROOK, NY / ACCESS Newswire / February 11, 2025 /Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the ...
Using a new technology and computational method, researchers from Fred Hutch Cancer Center and The University of Texas MD ...
STONY BROOK, NY / ACCESS Newswire / February 11, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today issued a reminder to it ...
Guardant Health is overcoming skepticism with new cancer tests. Learn why GH stock is a buy, with strong growth and a shift ...
The overall market of herpes simplex is expected to boost with the expected launch of emerging therapy, increased awareness, and extensive research in the forecast period (2025-2034). LAS ...
Researchers determined the clinical classification of more than 90% of potential BRCA2 variants of uncertain significance in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback